CEO of SFDA Discusses “Regulatory Pathways: Balancing Innovation and Safety” at the Global Healthspan Summit 2025

  • Post author:
  • Post category:

The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, contributed his insights to a prominent panel discussion on “Regulatory Pathways: Balancing Innovation…

Continue ReadingCEO of SFDA Discusses “Regulatory Pathways: Balancing Innovation and Safety” at the Global Healthspan Summit 2025